Laura E. Zawadzke

Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1

Mark E. Schnute, Matthew D. McReynolds, Tom Kasten et al. · Biochemical Journal · 2012 · 274 citations

Specific Inhibitor, Whole Blood, Cellular Physiology +20

Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes

Qing‐Jun Meng, Elizabeth S. Maywood, David A. Bechtold et al. · Proceedings of the National Academy of Sciences · 2010 · 255 citations · Full text

Existence of two D-alanine:D-alanine ligases in Escherichia coli: cloning and sequencing of the ddlA gene and purification and characterization of the DdlA and DdlB enzymes

Laura E. Zawadzke, Timothy D. H. Bugg, C T Walsh · Biochemistry · 1991 · 132 citations

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

Andrew R. Conery, Richard C. Centore, Adrianne Neiss et al. · eLife · 2016 · 118 citations · Full text

Hematological Malignancy, Bromodomain Inhibition, Malignant Blood Disorder +9

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

Terry D. Crawford, Vickie Tsui, E. Megan Flynn et al. · Journal of Medicinal Chemistry · 2016 · 117 citations · Full text

Molecular Biology, Chemical Biology, Pharmaceutical Chemistry +17